These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9565970)

  • 61. Autocrine interleukin-1 receptor antagonist can support malignant growth of glioblastoma by blocking growth-inhibiting autocrine loop of interleukin-1.
    Oelmann E; Kraemer A; Serve H; Reufi B; Oberberg D; Patt S; Herbst H; Stein H; Thiel E; Berdel WE
    Int J Cancer; 1997 Jun; 71(6):1066-76. PubMed ID: 9185713
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Endotoxin-induced cytokine gene expression in vivo. IV. Expression of interleukin-1 alpha/beta and interleukin-1 receptor antagonist mRNA during endotoxemia and during endotoxin-initiated local acute inflammation.
    Ulich TR; Guo K; Yin S; del Castillo J; Yi ES; Thompson RC; Eisenberg SP
    Am J Pathol; 1992 Jul; 141(1):61-8. PubMed ID: 1385928
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
    Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lipopolysaccharide induces human interleukin-1 receptor antagonist and interleukin-1 production in the same cell.
    Andersson J; Björk L; Dinarello CA; Towbin H; Andersson U
    Eur J Immunol; 1992 Oct; 22(10):2617-23. PubMed ID: 1396967
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of interleukin-1 beta and interleukin-1 receptor antagonist in oxLDL-treated human aortic smooth muscle cells and in the neointima of cholesterol-fed endothelia-denuded rabbits.
    Lin SJ; Yen HT; Chen YH; Ku HH; Lin FY; Chen YL
    J Cell Biochem; 2003 Mar; 88(4):836-47. PubMed ID: 12577317
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Expression and distribution of vascular endothelial growth factor protein in human brain tumors.
    Pietsch T; Valter MM; Wolf HK; von Deimling A; Huang HJ; Cavenee WK; Wiestler OD
    Acta Neuropathol; 1997 Feb; 93(2):109-17. PubMed ID: 9039457
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Live Borrelia burgdorferi preferentially activate interleukin-1 beta gene expression and protein synthesis over the interleukin-1 receptor antagonist.
    Miller LC; Isa S; Vannier E; Georgilis K; Steere AC; Dinarello CA
    J Clin Invest; 1992 Sep; 90(3):906-12. PubMed ID: 1387885
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Barrier disruption increases gene expression of cytokines and the 55 kD TNF receptor in murine skin.
    Wood LC; Stalder AK; Liou A; Campbell IL; Grunfeld C; Elias PM; Feingold KR
    Exp Dermatol; 1997 Apr; 6(2):98-104. PubMed ID: 9209892
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Induction of interleukin-1 receptor antagonist (IL-1ra) following surgery is associated with major trauma.
    O'Nualláin EM; Puri P; Mealy K; Reen DJ
    Clin Immunol Immunopathol; 1995 Jul; 76(1 Pt 1):96-101. PubMed ID: 7606873
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Analysis of interleukin-13 receptor alpha2 expression in human pediatric brain tumors.
    Kawakami M; Kawakami K; Takahashi S; Abe M; Puri RK
    Cancer; 2004 Sep; 101(5):1036-42. PubMed ID: 15329913
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Expression of KIT receptor tyrosine kinase in endothelial cells of juvenile brain tumors.
    Puputti M; Tynninen O; Pernilä P; Salmi M; Jalkanen S; Paetau A; Sihto H; Joensuu H
    Brain Pathol; 2010 Jul; 20(4):763-70. PubMed ID: 20030644
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Strikingly higher interleukin (IL)-1alpha, IL-1beta and soluble interleukin-1 receptor antagonist (sIL-1RA) but similar IL-2, sIL-2R, IL-3, IL-4, IL-6, sIL-6R, IL-10, tumour necrosis factor (TNF)-alpha, transforming growth factor (TGF)-beta and interferon IFN-gamma urine levels in healthy females compared to healthy males: protection against urinary tract injury?
    Sadeghi M; Daniel V; Naujokat C; Weimer R; Opelz G
    Clin Exp Immunol; 2005 Nov; 142(2):312-7. PubMed ID: 16232218
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Induction of the interleukin 1 receptor antagonist protein by transforming growth factor-beta.
    Turner M; Chantry D; Katsikis P; Berger A; Brennan FM; Feldmann M
    Eur J Immunol; 1991 Jul; 21(7):1635-9. PubMed ID: 1829411
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pro-inflammatory and anti-inflammatory cytokine mRNA induction in the periphery and brain following intraperitoneal administration of bacterial lipopolysaccharide.
    Turrin NP; Gayle D; Ilyin SE; Flynn MC; Langhans W; Schwartz GJ; Plata-Salamán CR
    Brain Res Bull; 2001 Mar; 54(4):443-53. PubMed ID: 11306198
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor.
    Loscher CE; Mills KH; Lynch MA
    J Neuroimmunol; 2003 Apr; 137(1-2):117-24. PubMed ID: 12667655
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lipopolysaccharide from Actinobacillus actinomycetemcomitans stimulates production of interleukin-1beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-1 receptor antagonist in human whole blood.
    Schytte Blix IJ; Helgeland K; Hvattum E; Lyberg T
    J Periodontal Res; 1999 Jan; 34(1):34-40. PubMed ID: 10086884
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Expression of interleukin 1 alpha, interleukin 1 beta and interleukin 1 receptor antagonist mRNA in mouse brain: regulation by bacterial lipopolysaccharide (LPS) treatment.
    Gabellec MM; Griffais R; Fillion G; Haour F
    Brain Res Mol Brain Res; 1995 Jul; 31(1-2):122-30. PubMed ID: 7476020
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Preoperative systemic levels of VEGFA, IL-7, IL-17A, and TNF-β delineate two distinct groups of children with brain tumors.
    Sandén E; Enríquez Pérez J; Visse E; Kool M; Carén H; Siesjö P; Darabi A
    Pediatr Blood Cancer; 2016 Dec; 63(12):2112-2122. PubMed ID: 27472224
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Inhibition of kainic acid induced expression of interleukin-1 beta and interleukin-1 receptor antagonist mRNA in the rat brain by NMDA receptor antagonists.
    Eriksson C; Zou LP; Ahlenius S; Winblad B; Schultzberg M
    Brain Res Mol Brain Res; 2000 Dec; 85(1-2):103-13. PubMed ID: 11146112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.